About Rivermark
Rivermark is a company based in Milwaukee (United States) founded in 2021 by Andy Doraiswamy.. Rivermark has raised $34.16 million across 2 funding rounds from investors including American Century Investments, Venture Investors and Time BioVentures. Rivermark offers products and services including FloStent. Rivermark operates in a competitive market with competitors including Neotract, Zenflow, Urotronic, Butterfly Medical and ProVerum Medical, among others.
- Headquarter Milwaukee, United States
- Founders Andy Doraiswamy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rivermark Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$34.16 M (USD)
in 2 rounds
-
Latest Funding Round
$30.04 M (USD), Series C
Sep 27, 2024
-
Investors
American Century Investments
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Rivermark
Rivermark offers a comprehensive portfolio of products and services, including FloStent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Device for BPH treatment to restore urinary flow quickly.
Funding Insights of Rivermark
Rivermark has successfully raised a total of $34.16M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $30.04 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series C — $30.0M
-
First Round
First Round
(20 Jul 2023)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2024 | Amount | Series C - Rivermark | Valuation | American Century Investments | |
| Jul, 2023 | Amount | Series A - Rivermark | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Rivermark
Rivermark has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include American Century Investments, Venture Investors and Time BioVentures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science and healthcare sectors
|
Founded Year | Domain | Location | |
|
Early-stage medical and health technology investments are facilitated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Rivermark
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Rivermark
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rivermark Comparisons
Competitors of Rivermark
Rivermark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neotract, Zenflow, Urotronic, Butterfly Medical and ProVerum Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive devices in urology
|
|
| domain | founded_year | HQ Location |
A device is developed to treat urinary obstruction from BPH.
|
|
| domain | founded_year | HQ Location |
Urethral stricture treatment devices are developed by Urotronic.
|
|
| domain | founded_year | HQ Location |
Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH)
|
|
| domain | founded_year | HQ Location |
Developer of a minimally-invasive medical device for benign prostatic hyperplasia
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rivermark
Frequently Asked Questions about Rivermark
When was Rivermark founded?
Rivermark was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Rivermark located?
Rivermark is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.
Who is the current CEO of Rivermark?
Adam Kadlec is the current CEO of Rivermark.
Is Rivermark a funded company?
Rivermark is a funded company, having raised a total of $34.16M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.12M, raised on Jul 20, 2023.
What does Rivermark do?
Established in 2021 in Milwaukee, United States, the company operates in the medical device sector. Focus is placed on a minimally invasive solution called FloStent, which utilizes a nitinol stent to keep the prostatic urethra open. Normal urinary function is thereby restored for patients with benign prostatic hyperplasia. Leadership includes co-founder Andy Doraiswamy as chairman and Adam Kadlec as CEO.
Who are the top competitors of Rivermark?
What products or services does Rivermark offer?
Rivermark offers FloStent.
Who are Rivermark's investors?
Rivermark has 6 investors. Key investors include American Century Investments, Venture Investors, Time BioVentures, View Ventures, and Cadence Healthcare Ventures.